Citadel Advisors - ALLOVIR INC ownership

ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 86 filers reported holding ALLOVIR INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$75,465
-92.3%
35,100
-87.8%
0.00%
Q2 2023$976,031
+100.9%
287,068
+132.8%
0.00%
Q1 2023$485,845
-14.0%
123,311
+12.0%
0.00%
Q4 2022$564,726
+59.1%
110,083
+144.6%
0.00%
Q3 2022$355,000
+298.9%
45,000
+98.2%
0.00%
Q2 2022$89,000
-87.9%
22,700
-79.2%
0.00%
Q1 2022$736,000
-20.9%
108,945
+51.5%
0.00%
Q4 2021$931,000
+97.7%
71,915
+282.5%
0.00%
Q3 2021$471,000
-55.5%
18,800
-51.2%
0.00%
Q3 2020$1,059,00038,5110.00%
Other shareholders
ALLOVIR INC shareholders Q2 2022
NameSharesValueWeighting ↓
Artal Group S.A. 5,577,167$44,004,0001.88%
GMT CAPITAL CORP 2,758,846$21,767,0001.35%
Regency Capital Management Inc.\DE 75,010$592,0000.73%
Redmile Group, LLC 1,907,969$15,054,0000.58%
Samsara BioCapital, LLC 82,336$650,0000.15%
Alkeon Capital Management 4,923,104$38,843,0000.13%
Woodline Partners LP 1,087,093$8,577,0000.12%
GSA CAPITAL PARTNERS LLP 77,625$612,0000.08%
CORNERCAP INVESTMENT COUNSEL INC 44,987$355,0000.07%
AMERICAN INTERNATIONAL GROUP, INC. 1,143,634$9,023,0000.07%
View complete list of ALLOVIR INC shareholders